Dr. Lal PathLabs Ltd (DLPA)

NSE
Currency in INR
2,447.80
-55.10(-2.20%)
Closed
DLPA Scorecard
Full Analysis
2 analysts have revised their earnings downwards for the upcoming period
Fair Value
Day's Range
2,440.652,517.45
52 wk Range
2,165.803,653.95
Key Statistics
Edit
Bid/Ask
2,449.00 / 2,447.80
Prev. Close
2,447.8
Open
2,503
Day's Range
2,440.65-2,517.45
52 wk Range
2,165.8-3,653.95
Volume
223.43K
Average Vol. (3m)
233.71K
1-Year Change
17.58%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DLPA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
3,105.65
Upside
+26.88%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Dr. Lal PathLabs Ltd Company Profile

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Employees
4099
Market
India

Compare DLPA to Peers and Sector

Metrics to compare
DLPA
Peers
Sector
Relationship
P/E Ratio
49.3x39.5x−0.5x
PEG Ratio
1.870.490.00
Price / Book
10.3x3.1x2.6x
Price / LTM Sales
8.6x3.7x3.0x
Upside (Analyst Target)
32.3%29.6%55.6%
Fair Value Upside
Unlock12.8%10.1%Unlock

Analyst Ratings

14 Buy
2 Hold
7 Sell
Ratings:
23 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 3,105.65
(+26.88% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 50.14%
Dividend Yield
0.96%
Industry Median 0.26%
Annualized Payout
24.00
Paid unevenly
5-Years Growth
+9.14%
Growth Streak

Earnings

Latest Release
Jan 30, 2025
EPS / Forecast
11.60 / 11.60
Revenue / Forecast
5.97B / 6.00B
EPS Revisions
Last 90 days

People Also Watch

18.66
INFY
-0.93%
2,069.20
INMR
-1.29%
3,683.05
COMU
+0.67%
25.70
HAL
+0.04%
234.45
RITS
-4.83%

FAQ

What Is the Dr. Lal PathLabs (DLPA) Stock Price Today?

The Dr. Lal PathLabs stock price today is 2,447.80

What Stock Exchange Does Dr. Lal PathLabs Trade On?

Dr. Lal PathLabs is listed and trades on the NSE stock exchange.

What Is the Stock Symbol for Dr. Lal PathLabs?

The stock symbol for Dr. Lal PathLabs is "DLPA."

Does Dr. Lal PathLabs Pay Dividends? What’s The Current Dividend Yield?

The Dr. Lal PathLabs dividend yield is 0.98%.

What Is the Dr. Lal PathLabs Market Cap?

As of today, Dr. Lal PathLabs market cap is 203.97B.

What is Dr. Lal PathLabs Earnings Per Share?

The Dr. Lal PathLabs EPS is 50.14.

What Is the Next Dr. Lal PathLabs Earnings Date?

Dr. Lal PathLabs will release its next earnings report on May 16, 2025.

From a Technical Analysis Perspective, Is DLPA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.